IMAB362-vcMMAE

N/A

Report date: 2025/05/14 14:16:52

Base Information

Drug NameIMAB362-vcMMAE

Drug Alias NameIMAB362-vcMMAEIMAB-362-vcMMAE

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-CLDN18

TargetsClaudin-18 splice variant 2

Therapy Area/IndicationsPancreatic NeoplasmsStomach Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGanymed Pharmaceuticals Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesGanymed Pharmaceuticals Gmbh

Inactive CompaniesN/A

Active IndicationsPancreatic NeoplasmsStomach Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A